European Innovation Council · Running
PACT4EYE Innovative Photoactivated Ruthenium Chemotherapy to treat eye cancer
- Coordinator
- Universiteit Leiden, Netherlands
- Runs
- 1 November 2023 to 31 October 2026
- Status
- Running
- EU funding
- €2.5m
- Total cost
- €2.5m
- Partners
- 4 organisations in 3 countries
- Type
- European Innovation Council
- Grant agreement
- 101136703
What the project is doing
In the project's own words, from its summary on CORDIS.
Uveal melanoma (UM) is a rare tumor of the eye
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Universiteit Leiden | Leiden | Netherlands | Coordinator |
| Institut Curie | Paris | France | Participant |
| Recornea SRL | Martignacco Ud | Italy | Participant |
| Academisch Ziekenhuis Leiden | Leiden | Netherlands | Participant |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI